Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses

Autoimmunity

Volumn 50, Issue 3, 2017, Pages 170-181

  Kontaki, Eleni ^a   Boumpas, Dimitrios T ^a   Tzardi, Maria ^b   Mouzas, Ioannis A ^b   Papadakis, Konstantinos A ^b   Verginis, Panayotis ^c  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

BM MDSCs; CEBP ; experimental colitis; IBD; MDSCs

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CD14 ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; CD4 ANTIGEN; TRINITROBENZENESULFONIC ACID; BIOLOGICAL MARKER; CYTOKINE; LEUKOCYTE ANTIGEN;

ADOPTIVE TRANSFER; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROHN DISEASE ACTIVITY INDEX; DOWN REGULATION; EFFECTOR CELL; EXPERIMENTAL COLITIS; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; STEADY STATE; STEM CELL EXPANSION; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; ANIMAL; COLITIS; DISEASE MODEL; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, CD; BIOMARKERS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELLULAR MICROENVIRONMENT; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOMODULATION; IMMUNOPHENOTYPING; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTE ACTIVATION; MICE; MYELOID-DERIVED SUPPRESSOR CELLS; T-LYMPHOCYTE SUBSETS;

EID: 85014434909     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916934.2017.1283405     Document Type: Article

References (46)

1. Xavier, R. J., and D. K., Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 448:427–434
2. Kaser, A., S., Zeissig, and R. S., Blumberg. 2010. Inflammatory bowel disease. Annu. Rev. Immunol. 28:573–621
3. Melgar, S., and F., Shanahan. 2010. Inflammatory bowel disease–from mechanisms to treatment strategies. Autoimmunity. 43:463–477
4. Monteleone, G., D., Fina, R., Caruso, et al. 2006. New mediators of immunity and inflammation in inflammatory bowel disease. Curr. Opin. Gastroenterol. 22:361–364
5. Shih, D. Q., and S. R., Targan. 2008. Immunopathogenesis of inflammatory bowel disease. World J. Gastroenterol. 14:390–400
6. Pizarro, T. T., and F., Cominelli. 2007. Cytokine therapy for Crohn's disease:advances in translational research. Annu. Rev. Med. 58:433–444
7. Hardenberg, G., T. S., Steiner, and M. K., Levings. 2011. Environmental influences on T regulatory cells in inflammatory bowel disease. Semin. Immunol. 23:130–138
8. Gabrilovich, D. I., and S., Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:162–174
9. Gabrilovich, D. I., V., Bronte, S. H., Chen, et al. 2007. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 67:425. Author reply 426
10. Ribechini, E., V., Greifenberg, S., Sandwick, et al. 2010. Subsets, expansion and activation of myeloid-derived suppressor cells. Med. Microbiol. Immunol. 199:273–281
11. Youn, J. I., S., Nagaraj, M., Collazo, et al. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181:5791–5802
12. Ochoa, A. C., A. H., Zea, C., Hernandez, et al. 2007. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin. Cancer Res. 13:721s–726s
13. Almand, B., J. I., Clark, E., Nikitina, et al. 2001. Increased production of immature myeloid cells in cancer patients:a mechanism of immunosuppression in cancer. J. Immunol. 166:678–689
14. Ioannou, M., T., Alissafi, I., Lazaridis, et al. 2012. Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J. Immunol. 188:1136–1146
15. Vlachou, K., K., Mintzas, M., Glymenaki, et al. 2016. Elimination of granulocytic myeloid-derived suppressor cells in lupus-prone mice linked to reactive oxygen species-dependent extracellular trap formation. Arthritis Rheumatol. 68:449–461
16. Nagaraj, S., M., Collazo, C. A., Corzo, et al. 2009. Regulatory myeloid suppressor cells in health and disease. Cancer Res. 69:7503–7506
17. Rabinovich, G. A., D., Gabrilovich, and E. M., Sotomayor. 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25:267–296
18. Marigo, I., L., Dolcetti, P., Serafini, et al. 2008. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 222:162–179
19. Serafini, P., I., Borrello, and V., Bronte. 2006. Myeloid suppressor cells in cancer:recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16:53–65
20. Delano, M. J., P. O., Scumpia, J. S., Weinstein, et al. 2007. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204:1463–1474
21. Garcia, M. R., L., Ledgerwood, Y., Yang, et al. 2010. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J. Clin. Invest. 120:2486–2496
22. Marigo, I., E., Bosio, S., Solito, et al. 2010. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity. 32:790–802
23. Boros, P., J. C., Ochando, S. H., Chen, et al. 2010. Myeloid-derived suppressor cells:natural regulators for transplant tolerance. Hum. Immunol. 71:1061–1066
24. La Cava, A., 2011. Regulatory immune cell subsets in autoimmunity. Autoimmunity. 44:1–2
25. Cripps, J. G., and J. D., Gorham. 2011. MDSC in autoimmunity. Int. Immunopharmacol. 11:789–793
26. Zhang, Q., M., Fujino, J., Xu, et al. 2015. The role and potential therapeutic application of myeloid-derived suppressor cells in allo- and autoimmunity. Mediators Inflamm. 2015:421927
27. Crook, K. R., and P., Liu. 2014. Role of myeloid-derived suppressor cells in autoimmune disease. World J. Immunol. 4:26–33
28. Ioannou, M., T., Alissafi, L., Boon, et al. 2013. In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells. J. Immunol. 190:2631–2640
29. Condamine, T., and D. I., Gabrilovich. 2011. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 32:19–25
30. Peranzoni, E., S., Zilio, I., Marigo, et al. 2010. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 22:238–244
31. Youn, J. I., and D. I., Gabrilovich. 2010. The biology of myeloid-derived suppressor cells:the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 40:2969–2975
32. Guan, Q., S., Moreno, G., Qing, et al. 2013. The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis. J. Leukoc. Biol. 94:803–811
33. Haile, L. A., R., von Wasielewski, J., Gamrekelashvili, et al. 2008. Myeloid-derived suppressor cells in inflammatory bowel disease:a new immunoregulatory pathway. Gastroenterology. 135:871–881. 881.e1–5
34. Su, H., X., Cong, and Y. L., Liu. 2013. Transplantation of granulocytic myeloid-derived suppressor cells (G-MDSCs) could reduce colitis in experimental murine models. J. Dig. Dis. 14:251–258
35. Varol, C., A., Vallon-Eberhard, E., Elinav, et al. 2009. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity. 31:502–512
36. Ostanin, D. V., E., Kurmaeva, K., Furr, et al. 2012. Acquisition of antigen-presenting functions by neutrophils isolated from mice with chronic colitis. J. Immunol. 188:1491–1502
37. Rivollier, A., J., He, A., Kole, et al. 2012. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209:139–155
38. Scheiffele, F., and I. J., Fuss. 2002. Induction of TNBS colitis in mice. Curr. Protoc. Immunol. 49:15.19:15.19.1–15.19.14
39. Weigmann, B., I., Tubbe, D., Seidel, et al. 2007. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2:2307–2311
40. Rossner, S., C., Voigtlander, C., Wiethe, et al. 2005. Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur. J. Immunol. 35:3533–3544
41. Srivastava, M. K., L., Zhu, M., Harris-White, et al. 2012. Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS One. 7:e40677
42. Fujii, W., E., Ashihara, H., Hirai, et al. 2013. Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis. J. Immunol. 191:1073–1081
43. Guo, C., F., Hu, H., Yi, et al. 2016. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis. Ann. Rheum. Dis. 75:278–285
44. Xi, Q., Y., Li, J., Dai, et al. 2015. High frequency of mononuclear myeloid-derived suppressor cells is associated with exacerbation of inflammatory bowel disease. Immunol. Invest. 44:279–287
45. Zhang, R., S., Ito, N., Nishio, et al. 2011. Dextran sulphate sodium increases splenic Gr1(+)CD11b(+) cells which accelerate recovery from colitis following intravenous transplantation. Clin. Exp. Immunol. 164:417–427
46. Zhang, H., H., Nguyen-Jackson, A. D., Panopoulos, et al. 2010. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood. 116:2462–2471